| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |